PEPentwater Capital Management LP
Institutional investor · Portfolio as of Q4 2020
Top Holdings235 positions
| 2.4M | $883.7M | 10.7% | — | — | — | Decreased — | |
MAXIM INTEGRATED PRODS INC | 9M | $797.9M | 9.6% | — | — | 2 qtrssince 2020-Q3 | Increased 76 |
SLACK TECHNOLOGIES INC | 18.1M | $764.8M | 9.2% | — | — | 1 qtr | New 98 |
TIFFANY & CO NEW | 5.4M | $704.1M | 8.5% | — | — | 5 qtrssince 2019-Q4 | Increased 73 |
XILINX INC | 4M | $570.6M | 6.9% | — | — | 1 qtr | New 97 |
ALEXION PHARMACEUTICALS INC | 3M | $462.6M | 5.6% | — | — | 1 qtr | New 97 |
| 2.6M | $335.2M | 4.0% | — | — | — | Decreased — | |
GRUBHUB INC | 4M | $296M | 3.6% | — | — | 3 qtrssince 2020-Q2 | Increased 81 |
| 3.1M | $281.2M | 3.4% | — | — | 1 qtr | New 85 | |
VARIAN MED SYS INC | 1.4M | $242.4M | 2.9% | — | — | 2 qtrssince 2020-Q3 | Increased 79 |
TURQUOISE HILL RES LTD | 18.7M | $231.8M | 2.8% | — | — | 1 qtr | New 79 |
PG&E CORP | 17.4M | $216.2M | 2.6% | $10.96 | +11.35% | 8 qtrssince 2019-Q1 | Decreased 0 |
INPHI CORP | 1.2M | $195.6M | 2.4% | — | — | 1 qtr | New 79 |
DUPONT DE NEMOURS INC | 2.4M | $169.6M | 2.0% | $80.35 | +0.11% | 3 qtrssince 2020-Q2 | Increased 84 |
CHINA BIOLOGIC PRODS HLDGS I | 1.2M | $139.1M | 1.7% | — | — | 6 qtrssince 2019-Q3 | Increased 77 |
CORELOGIC INC | 1.7M | $131.8M | 1.6% | — | — | 2 qtrssince 2020-Q3 | Decreased 0 |
INTERNATIONAL FLAVORS&FRAGRA | 844,850 | $92M | 1.1% | $97.31 | -13.11% | 1 qtr | New 68 |
EATON VANCE CORP | 1.4M | $91.7M | 1.1% | — | — | 1 qtr | New 68 |
VICI PPTYS INC | 3.4M | $86.3M | 1.0% | $14.86 | +33.09% | 4 qtrssince 2020-Q1 | Decreased 0 |
SPDR S&P 500 ETF TR | 212,209 | $79.3M | 1.0% | $253.84 | +36.43% | 4 qtrssince 2020-Q1 | Decreased 0 |
Pentwater Capital Management LP manages $8.3B across 235 positions as of Q4 2020. Top holdings: SPDR S&P 500 ETF TR puts (10.7%), MXIM (9.6%), WORK (9.2%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.
Active quarter - 68 new positions, 58 exits, 36 increased. Top move: WORK (NEW, conviction 98). Portfolio: $8.3B across 235 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR